Tag: Botanix Pharmaceuticals
Botanix Pharmaceuticals: Passes FDA mid-cycle review for Sofpironium Bromide
Botanix Pharmaceuticals Passes FDA mid-cycle review for Sofpironium BromideBotanix Pharmaceuticals’ (BOT) lead product, Sofpironium Bromide, passes an FDA mid-cycle review
The FDA detected...
Botanix Pharmaceuticals: Ends Q1 FY21 financially strong
Botanix Pharmaceuticals has released its September quarterly report, showing the company ended the period with a strong $22.1M in the bank
That's enough...